Allergy/Imm Medical News about Quadrivalent Human Papillomavirus

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
Cancer Prevention Research, 10/08/09

Kjaer SK et al. – Efficacy in the intention–to–treat population tended to be lower in older women, women with more partners, and women with abnormal Pap test results. The efficacy of quadrivalent HPV vaccine against high–grade cervical and external anogenital neoplasia remains high through 42 months post vaccination.

<< Previous
The glutathione-S-transferase Mu 1 null genotype modulates...

Next >>
Early evaluation of natural killer activity in post-transplant...

ACIP Supports 'Permissive Use,' But Not Routine Use, of Gardasil in Males
American Family Physician, 10/29/09 Relevance Score: 79%

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09 Relevance Score: 79%

CDC Survey Shows Gains in Overall Adolescent Vaccination Rates for 2008. But Majority Still Lack Immunizations for Tdap, MCV4
American Family Physician, 10/23/09 Relevance Score: 79%

Rapid decline in presentations for genital warts after the implementation of a national quadrivalent human papillomavirus vaccination program for young women
Sexually Transmitted Infections, 10/22/09 Relevance Score: 78%

Human papillomavirus infection in Beijing, People's Republic of China: a population-based study
British Journal of Cancer, 10/01/09 Relevance Score: 68%